One such recent study reported hypermethylation and significant correlation of the expression of the GFPT2 gene with enrichment in the insulin resistance and insulin signalling pathways, suggesting that this gene is a suitable candidate biomarker for metabolic syndrome [85]. The gene discussed is GFPT2; the disease is metabolic syndrome.